• Skip to main content
  • Skip to footer

Qu Biologics

  • Who We Are
    • Mission and Values
    • Team and Board
  • What We Do
    • Transformational Science
    • SSI Platform
    • SSI Pipeline
    • Publications
  • Current Clinical Trials
    • RESILIENCE Study
    • PERIOP-06 Study
  • News
    • In the Press
    • Events
  • Investors
  • Careers
  • Contact
Search
Close Search
Home Hero
Home Hero

Investors

SSIs are not designed for incremental improvements to the ‘standard of treatment’ – they are designed to re-invent, complement, and replace the standard.

Dr. Simon Sutcliffe, Chief Medical Officer, Qu Biologics

Supported by a committed group of investors.

Qu Biologics is a private, clinical-stage biotechnology company. Qu Biologics has raised USD$39M in equity funding from high net worth, family offices, and angel investors, and an additional USD$12M in non-dilutive funding.  

Rather than blocking or stimulating a single receptor or pathway, SSI treatments are designed to restore the full depth and breadth of the body's normal immune response in a targeted organ. We believe this new approach has the potential to revolutionize the way cancer and chronic inflammatory diseases are treated and prevented. We are passionate and innovative and committed to achieve this goal and the full potential of SSIs.

Investment opportunity.

Qu Biologics is raising a Series B USD$25M equity round to expand our team and clinical development program to include a randomized double-blind placebo-controlled study in pancreatic cancer in addition to our current two enrolling studies. Please join us in transforming Medicine.

If you are interested in investment opportunities and learning more about our novel treatment approach and the innovative team behind it, please enter your contact information here, contact Chief Business Officer Andrew Rae at arae@qubiologics.com, or click on one of the three links, below, for additional information.

 

Learn More About Qu Biologics

Blog Post2
Executive Summary

Download
Blog Post2
Qu Biologics Introduction for Biotechnology Professionals
Download
Blog Post2
Qu Biologics Introduction for Non-Biotechnology Professionals
Download
Logo Light
  • Who We Are
  • What We Do
  • Our Current Trials
  • News
  • Investors
  • Careers
  • Contact
  • 4475 Wayburne Drive, Suite 305 Burnaby, B.C., Canada, V5G 4X4
  • 604.734.1450
    info@qubiologics.com

dashicons-facebook-alt
dashicons-twitter
dashicons-linkedin
dashicons-youtube

© 2023 Qu Biologics Inc. All Rights Reserved
| Terms of Use | Privacy Policy